SNCA and type 2 diabetes mellitus: Based on these findings, we speculate that in T2DM patients, hyperglycemia-induced neuroinflammation and α-synuclein deposition may affect brain regions that inhibit spinal motor neurons during REM sleep (59), potentially triggering iRBD (59).